Prescription products cannot be added to the shopping cart directly. Please contact us for verification.

fubiding desloratadine dispersible tablet 5mg per tablet 8tablets per box

Description

Indication & Scope

FuBiDing® (Desloratadine Dispersible Tablets) is indicated for the relief of symptoms associated with allergic rhinitis, including sneezing, rhinorrhea, nasal itching, nasal congestion, itchy eyes, and watery eyes. They are also indicated for the relief of pruritus and reduction of the number and size of wheals associated with chronic idiopathic urticaria.

Mechanism: Desloratadine is a long-acting, selective peripheral histamine H1-receptor antagonist. It inhibits histamine-mediated allergic responses, thereby reducing symptoms such as sneezing, itching, rhinorrhea, and urticaria.
Drug class: Second-generation, non-sedating antihistamine; selective peripheral H1-receptor antagonist.
Clinical use: Symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria in adults and appropriate pediatric patients.

Specification

Generic Name	Desloratadine Dispersible Tablets
Brand Name	FuBiDing®
Ingredient	Desloratadine
Dosage Form	Dispersible Tablet
Package	5 mg/tablet, 8 tablets/box
Conditions Treated	Allergic rhinitis and chronic idiopathic urticaria
Taboos	Hypersensitivity to desloratadine, loratadine, or any product excipient
Place of origin	China
Prescription type	Over-the-Counter (OTC) Drug
Storage Conditions	Store tightly closed in a cool, dry place at or below 20°C.
Manufacturer	Hainan Poly Pharm Co., Ltd.
Registration Authority	National Medical Products Administration (NMPA), China
Approval Number	H20040972
Approval Date	July 10, 2025
Shelf Life	24 months

How to use ?

Recommended Dose: Adults and adolescents aged 12 years and older: take 1 tablet (5 mg) once daily. Pediatric dosing should follow the approved labeling and medical advice.

Time: Take orally once daily, with or without food.

Instructions for use: The dispersible tablet may be dispersed in warm water before administration or swallowed directly with water. Do not exceed the recommended dose.

Interaction: Concomitant use with sedatives or other medicines that may cause drowsiness should be discussed with a physician or pharmacist. Patients should inform healthcare professionals about all medicines they are taking.

Side effects: Possible adverse reactions include dry mouth, headache, fatigue, dizziness, gastrointestinal discomfort, nausea, diarrhea, and, less commonly, palpitations, insomnia, or drowsiness. Hypersensitivity reactions may rarely occur.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is FuBiDing® (Desloratadine Dispersible Tablets)?

It is a second-generation antihistamine used to relieve symptoms of allergic rhinitis and chronic idiopathic urticaria.

What symptoms can it relieve?

It can relieve sneezing, runny or itchy nose, nasal congestion, itchy or watery eyes associated with allergic rhinitis, as well as itching and wheals associated with chronic idiopathic urticaria.

Does desloratadine cause drowsiness?

Desloratadine is generally considered a non-sedating or minimally sedating antihistamine. However, some individuals may still experience dizziness or drowsiness and should exercise caution when driving or operating machinery if affected.

When should medical attention be sought?

If allergic symptoms become severe, persist despite treatment, or are accompanied by difficulty breathing, facial or throat swelling, or other signs of a serious allergic reaction, immediate medical attention is required.